Ganga Pharmaceuticals Limited

BSE:539680 Stock Report

Market Cap: ₹113.7m

Ganga Pharmaceuticals Past Earnings Performance

Past criteria checks 1/6

Ganga Pharmaceuticals's earnings have been declining at an average annual rate of -46.2%, while the Personal Products industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 7.4% per year. Ganga Pharmaceuticals's return on equity is 0.4%, and it has net margins of 0.9%.

Key information

-46.2%

Earnings growth rate

-49.7%

EPS growth rate

Personal Products Industry Growth7.9%
Revenue growth rate-7.4%
Return on equity0.4%
Net Margin0.9%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Ganga Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:539680 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2326050
30 Jun 2326050
31 Mar 2326050
31 Dec 2226150
30 Sep 2226150
30 Jun 2225150
31 Mar 2225050
31 Dec 2125060
30 Sep 2125060
30 Jun 2124060
31 Mar 2124050
31 Dec 2026060
30 Sep 20280120
30 Jun 20301120
31 Mar 2031250
31 Dec 1930280
30 Sep 19302100
30 Jun 19322120
31 Mar 19342140
31 Dec 18352150
30 Sep 18372160
30 Jun 18342160
31 Mar 18311150
31 Dec 17301210
30 Sep 17291160
30 Jun 17291160
31 Mar 17301160
31 Dec 16280110
30 Sep 16270120
30 Jun 16270130
31 Mar 16260120
31 Mar 15280100
31 Mar 1427020

Quality Earnings: 539680 has high quality earnings.

Growing Profit Margin: 539680's current net profit margins (0.9%) are lower than last year (2.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 539680's earnings have declined by 46.2% per year over the past 5 years.

Accelerating Growth: 539680's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 539680 had negative earnings growth (-63%) over the past year, making it difficult to compare to the Personal Products industry average (10.6%).


Return on Equity

High ROE: 539680's Return on Equity (0.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.